Veeva DQS Processes 1M+ Subjects Across 1,000+ Studies, Automating Clinical Data Reconciliation
Event summary
- Veeva DQS has cleaned data for over 1 million subjects across more than 1,000 studies, automating 500,000+ queries.
- The system saves clinical teams thousands of hours in manual data reconciliation.
- Veeva DQS integrates AI for data classification and risk-based quality management (RBQM).
- Novo's VP highlights efficiency gains in managing clinical trial data volumes.
- Veeva Study Builder Agent was recently announced to streamline study configuration.
The big picture
Veeva DQS addresses the growing complexity of clinical trial data management, aligning with regulatory shifts toward risk-based monitoring. The system's automation capabilities position it as a strategic tool for sponsors and CROs grappling with increasing data volumes and protocol intricacy. Veeva's focus on next-generation data management reflects broader industry trends toward efficiency and compliance in clinical operations.
What we're watching
- Adoption Pace
- How quickly sponsors and CROs will scale Veeva DQS across larger studies.
- Regulatory Alignment
- Whether Veeva DQS can sustain compliance with evolving ICH E6(R3) guidelines.
- Competitive Differentiation
- The extent to which AI-driven data classification sets Veeva apart from rivals.
Related topics